HIV Protease Substrate V

INQUIRY Add to cart

For Research Use Only | Not For Clinical Use

CAT	IAR4241129
MDL Number	MFCD03444580
Molecular Weight	963.11

Description	>98% (HPLC)
Assay	>98% (HPLC)
Size	1MG
Storage Conditions	−20°C

A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism

Monique Nijhuis, Noortje M van Maarseveen, Stephane Lastere, Pauline Schipper, Eoin Coakley, Bärbel Glass, Mirka Rovenska, Dorien de Jong, Colombe Chappey, Irma W Goedegebuure, Gabrielle Heilek-Snyder, etc.

PLoS Med. 2007 Jan;4(1):e36.

PMID: 17227139

Drug-resistant HIV-1 Protease Regains Functional Dynamics Through Cleavage Site Coevolution

Nevra Özer, Ayşegül Özen, Celia A Schiffer, Türkan Haliloğlu

Evol Appl. 2015 Feb;8(2):185-98.

PMID: 25685193

HIV-1 Protease Flaps Spontaneously Close to the Correct Structure in Simulations Following Manual Placement of an Inhibitor Into the Open State

Viktor Hornak, Asim Okur, Robert C Rizzo, Carlos Simmerling

J Am Chem Soc. 2006 Mar 8;128(9):2812-3.

PMID: 16506755

Nelfinavir and Ritonavir Kill Bladder Cancer Cells Synergistically by Inducing Endoplasmic Reticulum Stress

Akinori Sato, Takako Asano, Kazuki Okubo, Makoto Isono, Tomohiko Asano

Oncol Res. 2018 Mar 5;26(2):323-332.

PMID: 28560953

Specificity and Inhibition of Proteases From Human Immunodeficiency Viruses 1 and 2

A G Tomasselli, J O Hui, T K Sawyer, D J Staples, C Bannow, I M Reardon, W J Howe, D L DeCamp, C S Craik, R L Heinrikson

J Biol Chem. 1990 Aug 25;265(24):14675-83.

PMID: 2201691

* Products or Services Interested: HIV Protease Substrate V ()
* Your question
* Name
* Email
Verification Code

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.

Online Inquiry